Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 1:40 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 49–72 of 79 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Lymphatic Mapping Clear all

Conditions: Breast Cancer
Interventions: SLN mapping using technetium-99m +/- isosulfan blue dye, SLN mapping with ICG fluorescence using the Asimov Platform; Drug · Device
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Breast Cancer, Melanoma
Interventions: Methylene blue dye injection of sentinel lymph node; Procedure
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Vulvar Cancer
Interventions: Sentinel lymph node mapping; Procedure
Lead sponsor: Gynecologic Oncology Group; Network
Eligibility: Female only
Enrollment: 515 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 1999
U.S. locations: 72
States / cities: Little Rock, Arkansas • Long Beach, California • San Francisco, California + 53 more

Conditions: Lymphatic System
Interventions: Not listed
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 142 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Rectal Cancer
Interventions: Intraoperative Mobile Gamma Camera imaging, Endoscopic injection of 99mTc-sulfur colloid, Endoscopic injections of Spot, Preoperative flexible sigmoidoscopy, SPECT/CT; Other · Drug · Procedure + 1 more
Lead sponsor: University of Virginia; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2013
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Endometrial Cancer
Interventions: ISB dye and standard white light imaging, ICG dye and FireFly fluorescence imaging; Device
Lead sponsor: AdventHealth; Other
Eligibility: 18 Years to 85 Years · Female only
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 1
States / cities: Orlando, Florida

Conditions: Cutaneous Melanoma, Melanoma
Interventions: Sentinel Lymph Node Biopsy, Ultrasonography, Sonazoid; Procedure · Device · Drug
Lead sponsor: University of Southern California; Other
Eligibility: 19 Years and older
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Lung Cancer
Interventions: technetium-99; Radiation
Lead sponsor: Alliance for Clinical Trials in Oncology; Other
Eligibility: 18 Years and older
Enrollment: 46 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2009
U.S. locations: 12
States / cities: Lewes, Delaware • Newark, Delaware • Evanston, Illinois + 9 more

Conditions: Lung Cancer, Lymph Node Metastasis, Pathologic Processes
Interventions: Subjects undergoing a lung specimen lymph node dissection, Control group; Other
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years and older
Enrollment: 160 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Lung Cancer
Interventions: Near Infrared Imaging; Drug
Lead sponsor: Dana-Farber Cancer Institute; Other
Eligibility: 18 Years and older
Enrollment: 57 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2029
U.S. locations: 4
States / cities: Boston, Massachusetts

Conditions: Gastric Adenocarcinoma
Interventions: Gastrectomy, Indocyanine Green, Iron Conjugated Polymers in Saline Suspension; Procedure · Drug · Other
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Cervical Cancer
Interventions: Total Abdominal Radical Hysterectomy, Total Laparoscopic or Robotic Radical Hysterectomy; Procedure
Lead sponsor: Queensland Centre for Gynaecological Cancer; Government
Eligibility: 18 Years and older · Female only
Enrollment: 636 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2022
U.S. locations: 6
States / cities: Baltimore, Maryland • Las Vegas, Nevada • New York, New York + 3 more

Conditions: Invasive Breast Cancer
Interventions: Sentinel node mapping; Procedure
Lead sponsor: Stephen Povoski; Other
Eligibility: 18 Years and older · Female only
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2010
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Cancer
Interventions: Fluorescein; Drug
Lead sponsor: University of Utah; Other
Eligibility: 18 Years and older
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2016
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Breast Cancer
Interventions: axillary lymph node dissection, isosulfan blue based lymphatic mapping, quality-of-life assessment, Questionnaire administration; Procedure · Drug · Other
Lead sponsor: City of Hope Medical Center; Other
Eligibility: Female only
Enrollment: 39 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2014
U.S. locations: 3
States / cities: Duarte, California • Sacramento, California • Chapel Hill, North Carolina

Conditions: Lymphedema, Surgery, Breast Cancer
Interventions: OnLume Imaging System, Indocyanine green; Device · Drug
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years and older · Female only
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Prostate Cancer
Interventions: SPECT-CT imaging; Other
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older · Male only
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Sentinel Lymph Node Biopsy, Breast Cancer
Interventions: Tc 99m tilmanocept, Tc 99m filtered sulfur colloid; Drug
Lead sponsor: Memorial Health University Medical Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 86 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Savannah, Georgia

Conditions: Cervical Cancer, Endometrial Cancer
Interventions: 18F-Fluorodeoxyglucose (18F-FDG), PET/CT imaging, PET/MRI imaging; Radiation · Device
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2026
U.S. locations: 7
States / cities: Basking Ridge, New Jersey • Middletown, New Jersey • Montvale, New Jersey + 4 more

Conditions: Head and Neck Melanoma
Interventions: fluorescent cRGDY-PEG-Cy5.5-C dots; Drug
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 67 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2027
U.S. locations: 2
States / cities: New York, New York

Conditions: Breast Cancer, Melanoma
Interventions: Lymphoseek; Drug
Lead sponsor: Navidea Biopharmaceuticals; Industry
Eligibility: 18 Years and older
Enrollment: 186 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 14
States / cities: Alexander City, Alabama • Birmingham, Alabama • La Jolla, California + 9 more

Conditions: Colorectal Cancer, Gallbladder Cancer, Gastric Cancer, Pancreatic Cancer, Small Intestine Cancer
Interventions: Not listed
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years to 120 Years
Enrollment: 115 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1999 – 2010
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Stage I Breast Cancer, Stage II Breast Cancer
Interventions: Indocyanine Green Solution, Technetium Tc-99m Sulfur Colloid, Lymphoscintigraphy, Axillary Lymph Node Biopsy; Drug · Radiation · Procedure
Lead sponsor: Case Comprehensive Cancer Center; Other
Eligibility: Female only
Enrollment: 102 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Stage I Endometrial Carcinoma, Stage II Endometrial Carcinoma, Stage III Endometrial Carcinoma, Stage IV Endometrial Carcinoma
Interventions: lymph node mapping, sentinel lymph node biopsy, isosulfan blue, indocyanine green solution, therapeutic conventional surgery, lymphadenectomy; Procedure · Drug
Lead sponsor: Case Comprehensive Cancer Center; Other
Eligibility: Female only
Enrollment: 58 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Cleveland, Ohio

Search by objective public record fields.

ICG and SLN Mapping

Second Echelon Node Study With Methylene Blue

Lymphatic Mapping in Treating Patients With Stage I or Stage II Cancer of the Vulva

Mapping and Quantifying Lymphatic Drainage of the Arm's Alternate Pathway

Feasibility Study to Develop Sentinel Lymph Node Mapping in Rectal Cancer Patients

Detection of SLN in Patients With Endometrial Cancer Undergoing Robotic Assisted Staging: Comparison of ISB and ICG

Sonazoid-Enhanced Ultrasound in Detecting Sentinel Lymph Node in Patients With Cutaneous Melanoma

Sentinel Lymph Node Mapping in Detecting Cancer That Has Spread to Lymph Nodes in Patients With Non-Small Cell Lung Cancer

Maximizing Lymph Node Dissection on Fresh and Fixed Lung Cancer Resection Specimens

Real-Time Image Guided Lymphatic Mapping and Nodal Targeting in Lung Cancer

Magnetic Sentinel Lymph Node Mapping in Gastric Cancer

Laparoscopic Approach to Cervical Cancer

Axillary Lymph Node Status After Completion of Preoperative Neoadjuvant Systemic Chemotherapy in Patients

Fluorescein for Lymphatic Mapping and Sentinel Lymph Node (SLN) Biopsy in Patients With Stage I and II Malignant Melanoma

Axillary Lymph Node Preservation Surgery in Reducing Lymphedema in Patients With Breast Cancer

Intraoperative Evaluation of Axillary Lymphatics

Feasibility of Using SPECT/CT Imaging to Map Lymphatic Drainage Patterns in Prostate Cancer Patients

Tilmanocept vs Sulfur Colloid in Sentinel Lymph Node Biopsy

Positron Lymphography Via Intracervical 18F-FDG Injection for Pre-surgical Lymphatic Mapping in Stage IB1 Cervical Cancer and High-grade Endometrial Cancer

Targeted Silica Nanoparticles for Real-Time Image-Guided Intraoperative Mapping of Nodal Metastases

Trial of Lymphoseek in Intraoperative Localization of Lymph Nodes in Breast Cancer and Melanoma

Visceral Lymphatic Mapping Using Isosulfan Blue in Patients With Cancer of the Pancreas, Colon, Stomach, Small Intestine, or Gallbladder

Comparison of Use of Indocyanine Green and 99mTc-labeled Radiotracer for Axillary Lymphatic Mapping in Patients With Breast Cancer

Lymph Node Mapping in Patients With Newly Diagnosed Endometrial Cancer Undergoing Surgery